Prognosis of IgA Vasculitis
IgA vasculitis (IgAV) has an excellent prognosis in children with most achieving complete symptom resolution, but adults face significantly worse outcomes with higher rates of chronic kidney disease and end-stage renal disease. 1, 2
Children: Generally Favorable Prognosis
The majority of children with IgAV who develop nephritis will do so within 3 months of presentation 1, making this the critical surveillance window. The overall prognosis in pediatric IgAV is excellent:
- Patient survival approaches 99% at 20 years 3
- Most cases are self-limiting with complete resolution of extrarenal manifestations
- Long-term comorbidity burden is similar to matched controls 3
- Children do not develop other rheumatic diseases as sequelae 3
Renal Complications in Children
While renal involvement occurs in approximately 30-46% of pediatric cases 4, the outcomes are generally good:
- Complete remission rates at 3 years are high, particularly in males ≤6 years old (84% vs 44% in females) 5
- End-stage renal disease can occur but remains uncommon 3
- Risk factors for poor 5-year renal prognosis include:
Short-term Complications in Children
While long-term prognosis is favorable, acute complications require vigilance:
- Severe gastrointestinal involvement occurs in approximately 8% (melena, intussusception) 4
- Testicular involvement is rare but possible 4
- Hospitalization rates are 3-fold higher in the first year following diagnosis (RR 3.41) 3
- Emergency department visits remain elevated in subsequent years (RR 1.29) 3
Adults: Significantly Worse Prognosis
Adult-onset IgAV represents a distinct clinical entity with considerably poorer outcomes than pediatric disease 2, 6:
Renal Complications in Adults
Kidney involvement is the major determinant of long-term prognosis in adults 2:
- Higher risk of progression to chronic kidney disease and end-stage renal disease compared to children 7, 6
- Chronic kidney disease is the most common long-term complication, with 3-year risk of 8.6% 8
- Adults should be assessed for secondary causes and malignancy with age-appropriate screening 1
Cardiovascular and Thrombotic Complications in Adults
Adults with IgAV face significantly elevated risks of major cardiovascular and thrombotic events 8:
Over 3 years, compared to matched controls, adults with IgAV have increased risks of:
- Myocardial infarction
- Atrial fibrillation
- Stroke
- Pulmonary embolism
- Venous thromboembolism
Disease Severity Factors in Adults
Predictors of adverse outcomes in adults include 6:
- Renal involvement at presentation
- Gastrointestinal involvement
- Older age at onset
- Medical comorbidities
Critical Monitoring Recommendations
For Children:
- Intensive surveillance for 3 months to detect nephritis development 1
- Urinalysis monitoring for hematuria and proteinuria
- If renal involvement develops, perform biopsy within 6 months of urinalysis abnormality to optimize prognosis 5
- Monitor serum cholesterol as prognostic marker 5
For Adults:
- Prolonged renal follow-up is essential, as abnormalities may appear months after initial presentation 6
- Screen for secondary causes and malignancy 1
- Monitor for cardiovascular and thrombotic complications 8
- Neither MEST-C classification nor International IgAN Prediction Tool has been validated in IgAV 1
Common Pitfalls to Avoid
Assuming adult IgAV behaves like pediatric disease - Adults require more aggressive monitoring and have worse outcomes 2, 6
Inadequate renal surveillance duration - Renal abnormalities can develop late; prolonged monitoring is mandatory 6
Delayed renal biopsy - Waiting >6 months from urinalysis abnormality to biopsy worsens 5-year prognosis 5
Missing the 3-month window in children - Most pediatric nephritis develops within this timeframe 1
Overlooking cardiovascular risk in adults - Adults face elevated risks of MI, stroke, and thromboembolism requiring appropriate monitoring 8